OncoTEX and Sterling Pharma Solutions sign clinical manufacturing agreement for the development of novel treatment against ovarian cancer
Read the full press release here OncoTEX Inc, an oncology company, and member of the iQ Group Global bioscience investment enterprise The iQ Group Global and Sterling Pharma Solutions, a global contract development and manufacturing organisation, have signed a clinical development agreement…